UNSPSC 51401536: Metaclazepam

This classification denotes a benzodiazepine with the molecular formula C18H18BrClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2N2B1303L, chemically known as 7-bromo-5-(o-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-1-methyl-1h-1,4-benzodiazepine but generally known as metaclazepam, which bears US NIH Compound Identifier 71272. European Medicines Agency schedules Metaclazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08800MIG.

UNSPSC 51401536 Metaclazepam is a Commodity code representing pharmaceutical products state and local governments procure for public health and emergency response programs. The sourced opportunity shows minimal alignment with the code's nominal scope — the Seminole County, Florida IFB solicits naloxone and safe drug deactivation systems for community health initiatives, neither of which are metaclazepam. The mismatch between the UNSPSC tag and the actual procurement suggests either miscoding by the issuing body or that metaclazepam procurement activity under this code does not surface in recent state and local contract notices. No other opportunities in the source validate the code's use for metaclazepam procurement.

The single opportunity on record originates from Seminole County's competitive bidding process (IFB 60459723LAS, posted June 30, 2026, with response due July 26, 2023). The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs, meet E-Verify and drug-free workplace certification requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract includes a two-year initial term with one-year renewal option and is potentially FEMA-funded. The source provides no other state or local solicitations under this code, leaving the geographic and issuing-body mix for metaclazepam procurement unclear.